The combination of WT1 and p53 can be used to distinguish serous carcinoma from endometrioid carcinoma, while the combination of WT1, Napsin A and ER are used to distinguish clear-cell carcinoma from serous carcinoma. The gene discussed is NAPSA; the disease is serous adenocarcinoma.